Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Sponsor: Jonsson Comprehensive Cancer Center
Summary
This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
51
Start Date
2016-02-03
Completion Date
2028-02-03
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
Conventional Surgery
Undergo surgery
Hypofractionated Radiation Therapy
Undergo hypofractionated radiation therapy
Laboratory Biomarker Analysis
Correlative studies
Questionnaire Administration
Ancillary studies
Locations (1)
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States